"I think most of the outside world thought we were crazy when we said we are going to do drug discovery" — Glenn Saldanha

Glenn Saldanha, a serious, highly focused and confident young man, seems extremely certain about his company’s growth path.

Five years ago, Glenmark was a small formulations company, the bulk of its revenues coming from India. Today, it is a radically transformed company focused on daring new drug discovery with two molecules in clinical trials and two landmark deals with leading foreign...

Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Free Helpline
Legal Credit